Dr. Molly Beth Lindquist Disbrow, MD

Dr. Disbrow practices at Stormont Vail Hospital in Topeka, Kansas, part of Stormont Vail Health.

Dr. Disbrow's NPI, 1730444886, was assigned on July 5, 2012. Dr. Disbrow holds Kansas license 04-42052.

Dr. Disbrow's primary practice is Stormont Vail Hospital, at 1500 Sw 10th Avenue, Topeka, KS 66604 in Shawnee County. The practice phone is (785) 354-6121.

Dr. Disbrow's primary practice is Stormont Vail Hospital in Topeka, Kansas, part of Stormont Vail Health. Dr. Disbrow is also affiliated with Ascension Via Christi Hospital in Manhattan. The medical group on file is Cotton O'Neil Clinic. Dmand AI also links Dr. Disbrow to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Disbrow practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Disbrow's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Disbrow is licensed in Kansas.

CMS data shows 494 Medicare services from Dr. Disbrow across 12 procedure codes in 2024, for 314 Medicare patients. Medicare paid $48,801 for them.

CMS counts 314 Medicare patients who saw Dr. Disbrow in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Disbrow's median patient age at 48, with 76% women.

In 2024, Dr. Disbrow wrote 249 Medicare Part D claims for 79 patients. 75% of them were for generic drugs. CMS names the drug for 119 of them, across 5 drugs with 11 or more claims each, at $25,522 in total drug cost. In 2023, CMS named 86 claims across 4 drugs.

Dr. Disbrow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Disbrow as offering telehealth. CMS counts 152 procedures of colonoscopy by Dr. Disbrow, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Disbrow, published from 2015 to 2017. 2015 was the busiest year, with 2. Dr. Disbrow's most frequent co-authors are Francisco Carlos Ramirez, MD, Harini A. Chakkera, MD and Lucinda A. Harris, MD.

CMS Open Payments shows 60 general payments to Dr. Disbrow from 13 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $493.